Aetna has developed a number of initiatives and partnerships to help address the social determinants of health for needy patients outside of the clinical setting, according to Harold L. Paz, MD, MS, executive vice president and chief medical officer at Aetna.
Aetna has developed a number of initiatives and partnerships to help address the social determinants of health for needy patients outside of the clinical setting, according to Harold L. Paz, MD, MS, executive vice president and chief medical officer at Aetna.
Transcript (slightly modified)
How is Aetna recognizing and addressing the impact of social determinants of health?
We have a number of different initiatives underway that look at that. We have our Healthy Community initiative through the Aetna Foundation, where we’re focusing on the issues within communities, the larger social issues within communities, that address health and health status and aim to increase the number of healthy days in a community.
We also have very focused approaches to do this. We just announced last month AetnaCare. AetnaCare is a new, innovative approach to driving improved health status for members, individuals, beginning with analytics, identifying individuals based on their needs, and then addressing that through the formation of care maps. Care maps look at the needs of individuals outside of the traditional care setting, so it’s not the same thing as a hospital protocol or an ED protocol, an emergency room protocol, but instead looks at the activation steps to improve health status for an individual, outside of the traditional care settings.
Focused primarily on the home and looking at how we can create a health ecosystem around the individual, bringing in various types of solutions such as exercise, nutrition, looking for ways to improve adherence to medication. And to take the steps necessary to avoid what are often the triggers for hospitalization and emergency room visits, particularly in individuals with complex medical conditions. That work is done in the home in this model by a nurse working alongside members that have a high degree of need.
Finally, in that health ecosystem is a series of partnerships that bring together various solutions to offer improved health status to individuals. We just announced our first partner in AetnaCare, and that’s Merck. Merck has included 2 of their diabetes drugs in the AetnaCare map for type 2 diabetes, and they’re taking financial risk on the outcomes because, again, we think that it’s important to, in creating these ecosystems, to create shared risks. Individuals have a financial risk through their health insurance, their deductibles, which as we know are not insignificant in this day and age. Employers do as well, the community does, in terms of the outcomes. So it in effect is pulling in social determinants of health, socioeconomic determinants of health, it’s looking at environmental determinants of health, which are all extraordinarily important and go beyond traditional healthcare per se.
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
2 Commerce Drive
Cranbury, NJ 08512